+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

GLP-1 Agonists Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology

  • PDF Icon

    Report

  • 83 Pages
  • March 2024
  • Region: Global
  • Prof Research
  • ID: 5950754
Description Jump to:

Quick Summary:

In the dynamic pharmaceutical landscape, the embrace of GLP-1 agonists has revolutionized the management of chronic conditions, crafting a market driven by innovation, efficacy, and an ever-expanding patient base. As senior business executives seeking to navigate the intricate terrain of this evolving industry, our comprehensive market research report offers a thorough analysis, vital for informed decision-making and strategic positioning.

Our meticulously constructed report provides an in-depth examination of the global GLP-1 agonists market, delving into geographical trends, competitive landscapes, and regional opportunities that are shaping the future of healthcare. With detailed profiles and SWOT analyses of key players, from industry giants to emerging entities, this document is an indispensable asset for articulating a robust business strategy, recognizing emerging patterns, and capturing market share in this high-potential sector.

This report describes the global market size of GLP-1 Agonists from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of GLP-1 Agonists as well as some smaller players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Companies Covered:

  • Novo Nordisk
  • Eli Lilly
  • GSK
  • AstraZeneca
  • Sanofi
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Glp-1 Agonists Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Glp-1 Agonists Market in North America (2019-2029)
8.1 Glp-1 Agonists Market Size
8.2 Glp-1 Agonists Market by End Use
8.3 Competition by Players/Suppliers
8.4 Glp-1 Agonists Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Glp-1 Agonists Market in South America (2019-2029)
9.1 Glp-1 Agonists Market Size
9.2 Glp-1 Agonists Market by End Use
9.3 Competition by Players/Suppliers
9.4 Glp-1 Agonists Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Glp-1 Agonists Market in Asia & Pacific (2019-2029)
10.1 Glp-1 Agonists Market Size
10.2 Glp-1 Agonists Market by End Use
10.3 Competition by Players/Suppliers
10.4 Glp-1 Agonists Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Glp-1 Agonists Market in Europe (2019-2029)
11.1 Glp-1 Agonists Market Size
11.2 Glp-1 Agonists Market by End Use
11.3 Competition by Players/Suppliers
11.4 Glp-1 Agonists Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Glp-1 Agonists Market in MEA (2019-2029)
12.1 Glp-1 Agonists Market Size
12.2 Glp-1 Agonists Market by End Use
12.3 Competition by Players/Suppliers
12.4 Glp-1 Agonists Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Glp-1 Agonists Market (2019-2024)
13.1 Glp-1 Agonists Market Size
13.2 Glp-1 Agonists Market by End Use
13.3 Competition by Players/Suppliers
13.4 Glp-1 Agonists Market Size by Type
Chapter 14 Global Glp-1 Agonists Market Forecast (2024-2029)
14.1 Glp-1 Agonists Market Size Forecast
14.2 Glp-1 Agonists Application Forecast
14.3 Competition by Players/Suppliers
14.4 Glp-1 Agonists Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Novo Nordisk
15.1.1 Company Profile
15.1.2 Main Business and GLP-1 Agonists Information
15.1.3 SWOT Analysis of Novo Nordisk
215.1.4 Novo Nordisk GLP-1 Agonists Revenue, Gross Margin and Market Share (2019-2024)
15.2 Eli Lilly
15.2.1 Company Profile
15.2.2 Main Business and GLP-1 Agonists Information
15.2.3 SWOT Analysis of Eli Lilly
215.2.4 Eli Lilly GLP-1 Agonists Revenue, Gross Margin and Market Share (2019-2024)
15.3 GSK
15.3.1 Company Profile
15.3.2 Main Business and GLP-1 Agonists Information
15.3.3 SWOT Analysis of GSK
215.3.4 GSK GLP-1 Agonists Revenue, Gross Margin and Market Share (2019-2024)
15.4 AstraZeneca
15.4.1 Company Profile
15.4.2 Main Business and GLP-1 Agonists Information
15.4.3 SWOT Analysis of AstraZeneca
215.4.4 AstraZeneca GLP-1 Agonists Revenue, Gross Margin and Market Share (2019-2024)
15.5 Sanofi
15.5.1 Company Profile
15.5.2 Main Business and GLP-1 Agonists Information
15.5.3 SWOT Analysis of Sanofi
215.5.4 Sanofi GLP-1 Agonists Revenue, Gross Margin and Market Share (2019-2024)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Glp-1 Agonists Report
Table Data Sources of Glp-1 Agonists Report
Table Major Assumptions of Glp-1 Agonists Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Glp-1 Agonists Picture
Table Glp-1 Agonists Classification
Table Glp-1 Agonists Applications
Table Drivers of Glp-1 Agonists Market
Table Restraints of Glp-1 Agonists Market
Table Opportunities of Glp-1 Agonists Market
Table Threats of Glp-1 Agonists Market
Table COVID-19 Impact For Glp-1 Agonists Market
Table Raw Materials Suppliers
Table Different Production Methods of Glp-1 Agonists
Table Cost Structure Analysis of Glp-1 Agonists
Table Key End Users
Table Latest News of Glp-1 Agonists Market
Table Merger and Acquisition
Table Planned/Future Project of Glp-1 Agonists Market
Table Policy of Glp-1 Agonists Market
Table 2019-2029 North America Glp-1 Agonists Market Size
Figure 2019-2029 North America Glp-1 Agonists Market Size and CAGR
Table 2019-2029 North America Glp-1 Agonists Market Size by Application
Table 2019-2024 North America Glp-1 Agonists Key Players Revenue
Table 2019-2024 North America Glp-1 Agonists Key Players Market Share
Table 2019-2029 North America Glp-1 Agonists Market Size by Type
Table 2019-2029 United States Glp-1 Agonists Market Size
Table 2019-2029 Canada Glp-1 Agonists Market Size
Table 2019-2029 Mexico Glp-1 Agonists Market Size
Table 2019-2029 South America Glp-1 Agonists Market Size
Figure 2019-2029 South America Glp-1 Agonists Market Size and CAGR
Table 2019-2029 South America Glp-1 Agonists Market Size by Application
Table 2019-2024 South America Glp-1 Agonists Key Players Revenue
Table 2019-2024 South America Glp-1 Agonists Key Players Market Share
Table 2019-2029 South America Glp-1 Agonists Market Size by Type
Table 2019-2029 Brazil Glp-1 Agonists Market Size
Table 2019-2029 Argentina Glp-1 Agonists Market Size
Table 2019-2029 Chile Glp-1 Agonists Market Size
Table 2019-2029 Peru Glp-1 Agonists Market Size
Table 2019-2029 Asia & Pacific Glp-1 Agonists Market Size
Figure 2019-2029 Asia & Pacific Glp-1 Agonists Market Size and CAGR
Table 2019-2029 Asia & Pacific Glp-1 Agonists Market Size by Application
Table 2019-2024 Asia & Pacific Glp-1 Agonists Key Players Revenue
Table 2019-2024 Asia & Pacific Glp-1 Agonists Key Players Market Share
Table 2019-2029 Asia & Pacific Glp-1 Agonists Market Size by Type
Table 2019-2029 China Glp-1 Agonists Market Size
Table 2019-2029 India Glp-1 Agonists Market Size
Table 2019-2029 Japan Glp-1 Agonists Market Size
Table 2019-2029 South Korea Glp-1 Agonists Market Size
Table 2019-2029 Southeast Asia Glp-1 Agonists Market Size
Table 2019-2029 Australia Glp-1 Agonists Market Size
Table 2019-2029 Europe Glp-1 Agonists Market Size
Figure 2019-2029 Europe Glp-1 Agonists Market Size and CAGR
Table 2019-2029 Europe Glp-1 Agonists Market Size by Application
Table 2019-2024 Europe Glp-1 Agonists Key Players Revenue
Table 2019-2024 Europe Glp-1 Agonists Key Players Market Share
Table 2019-2029 Europe Glp-1 Agonists Market Size by Type
Table 2019-2029 Germany Glp-1 Agonists Market Size
Table 2019-2029 France Glp-1 Agonists Market Size
Table 2019-2029 United Kingdom Glp-1 Agonists Market Size
Table 2019-2029 Italy Glp-1 Agonists Market Size
Table 2019-2029 Spain Glp-1 Agonists Market Size
Table 2019-2029 Belgium Glp-1 Agonists Market Size
Table 2019-2029 Netherlands Glp-1 Agonists Market Size
Table 2019-2029 Austria Glp-1 Agonists Market Size
Table 2019-2029 Poland Glp-1 Agonists Market Size
Table 2019-2029 Russia Glp-1 Agonists Market Size
Table 2019-2029 MEA Glp-1 Agonists Market Size
Figure 2019-2029 MEA Glp-1 Agonists Market Size and CAGR
Table 2019-2029 MEA Glp-1 Agonists Market Size by Application
Table 2019-2024 MEA Glp-1 Agonists Key Players Revenue
Table 2019-2024 MEA Glp-1 Agonists Key Players Market Share
Table 2019-2029 MEA Glp-1 Agonists Market Size by Type
Table 2019-2029 Egypt Glp-1 Agonists Market Size
Table 2019-2029 Israel Glp-1 Agonists Market Size
Table 2019-2029 South Africa Glp-1 Agonists Market Size
Table 2019-2029 Gulf Cooperation Council Countries Glp-1 Agonists Market Size
Table 2019-2029 Turkey Glp-1 Agonists Market Size
Table 2019-2024 Global Glp-1 Agonists Market Size by Region
Table 2019-2024 Global Glp-1 Agonists Market Size Share by Region
Table 2019-2024 Global Glp-1 Agonists Market Size by Application
Table 2019-2024 Global Glp-1 Agonists Market Share by Application
Table 2019-2024 Global Glp-1 Agonists Key Vendors Revenue
Figure 2019-2024 Global Glp-1 Agonists Market Size and Growth Rate
Table 2019-2024 Global Glp-1 Agonists Key Vendors Market Share
Table 2019-2024 Global Glp-1 Agonists Market Size by Type
Table 2019-2024 Global Glp-1 Agonists Market Share by Type
Table 2024-2029 Global Glp-1 Agonists Market Size by Region
Table 2024-2029 Global Glp-1 Agonists Market Size Share by Region
Table 2024-2029 Global Glp-1 Agonists Market Size by Application
Table 2024-2029 Global Glp-1 Agonists Market Share by Application
Table 2024-2029 Global Glp-1 Agonists Key Vendors Revenue
Figure 2024-2029 Global Glp-1 Agonists Market Size and Growth Rate
Table 2024-2029 Global Glp-1 Agonists Key Vendors Market Share
Table 2024-2029 Global Glp-1 Agonists Market Size by Type
Table 2024-2029 Glp-1 Agonists Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Novo Nordisk
  • Eli Lilly
  • GSK
  • AstraZeneca
  • Sanofi
  • Huadong Medicine
  • Shanghai Benemae Pharmaceutical Corporation
  • Hansoh Pharmaceutical

Methodology

Loading
LOADING...

Related Topics

Related Reports

Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Image

Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • 120 Pages
  • Global
From
Diabetes Drug Intelligence Center 2012-2023 - Product Image

Diabetes Drug Intelligence Center 2012-2023

  • Report
  • Global
From
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 181 Pages
  • Europe
From
Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Image

Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • 220 Pages
  • Global
From
Global Oral Anti-Diabetic Drugs Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Oral Anti-Diabetic Drugs Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 177 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.